Santin AD - Search Results

1

Improved survival of patients with hypermutation in uterine serous carcinoma.

Santin AD, Bellone S, Centritto F, Schlessinger J, Lifton R. Santin AD, et al. Gynecol Oncol Rep. 2015 Jan 24;12:3-4. doi: 10.1016/j.gore.2015.01.005. eCollection 2015 Apr. Gynecol Oncol Rep. 2015. PMID: 26076146 Free PMC article.

2

Overexpression of HER-2/neu in uterine serous papillary cancer.

Santin AD, Bellone S, Gokden M, Palmieri M, Dunn D, Agha J, Roman JJ, Hutchins L, Pecorelli S, O'Brien T, Cannon MJ, Parham GP. Santin AD, et al. Clin Cancer Res. 2002 May;8(5):1271-9. Clin Cancer Res. 2002. PMID: 12006548

3

Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.

Santin AD, Bellone S, Palmieri M, Bossini B, Dunn D, Roman JJ, Pecorelli S, Cannon M, Parham GP. Santin AD, et al. Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1345-55. doi: 10.1016/s0360-3016(02)03757-4. Int J Radiat Oncol Biol Phys. 2002. PMID: 12459356

4

Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix.

Santin AD, Bellone S, Palmieri M, Bossini B, Roman JJ, Cannon MJ, Bignotti E, Canè S, Pecorelli S. Santin AD, et al. Gynecol Oncol. 2003 May;89(2):271-80. doi: 10.1016/s0090-8258(03)00083-0. Gynecol Oncol. 2003. PMID: 12713991 Clinical Trial.

5

Selection of HER-2/neu-positive tumor cells in early stage cervical cancer: implications for Herceptin-mediated therapy.

Bellone S, Palmieri M, Gokden M, Joshua J, Roman JJ, Pecorelli S, Cannon MJ, Santin AD. Bellone S, et al. Among authors: santin ad. Gynecol Oncol. 2003 Oct;91(1):231-40. doi: 10.1016/s0090-8258(03)00460-8. Gynecol Oncol. 2003. PMID: 14529687

6

Increased levels of gangliosides in the plasma and ascitic fluid of patients with advanced ovarian cancer.

Santin AD, Ravindranath MH, Bellone S, Muthugounder S, Palmieri M, O'Brien TJ, Roman J, Cannon MJ, Pecorelli S. Santin AD, et al. BJOG. 2004 Jun;111(6):613-8. doi: 10.1111/j.1471-0528.2004.00142.x. BJOG. 2004. PMID: 15198791 Clinical Trial.

7

Current treatment options for endometrial cancer.

Santin AD, Bellone S, O'Brien TJ, Pecorelli S, Cannon MJ, Roman JJ. Santin AD, et al. Expert Rev Anticancer Ther. 2004 Aug;4(4):679-89. doi: 10.1586/14737140.4.4.679. Expert Rev Anticancer Ther. 2004. PMID: 15270671 Review.

8

The serine protease stratum corneum chymotryptic enzyme (kallikrein 7) is highly overexpressed in squamous cervical cancer cells.

Santin AD, Cane' S, Bellone S, Bignotti E, Palmieri M, De Las Casas LE, Roman JJ, Anfossi S, O'Brien T, Pecorelli S. Santin AD, et al. Gynecol Oncol. 2004 Aug;94(2):283-8. doi: 10.1016/j.ygyno.2004.05.023. Gynecol Oncol. 2004. PMID: 15297163 Free article.

9

Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer.

Santin AD, Bellone S, Siegel ER, Palmieri M, Thomas M, Cannon MJ, Kay HH, Roman JJ, Burnett A, Pecorelli S. Santin AD, et al. Am J Obstet Gynecol. 2005 Mar;192(3):813-8. doi: 10.1016/j.ajog.2004.10.605. Am J Obstet Gynecol. 2005. PMID: 15746676

10

Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.

Santin AD, Diamandis EP, Bellone S, Soosaipillai A, Cane S, Palmieri M, Burnett A, Roman JJ, Pecorelli S. Santin AD, et al. Clin Cancer Res. 2005 May 1;11(9):3320-5. doi: 10.1158/1078-0432.CCR-04-2528. Clin Cancer Res. 2005. PMID: 15867230 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

330 results

Search Page

Filters